SARAH DUBAN: Open Payments
NPI 1326387176 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 11 payments from 6 companies in 2025. Trend: 2023 $529 · 2024 $592 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $168 |
| Lilly USA, LLC | 2 | $145 |
| Amgen Inc. | 1 | $121 |
| Corcept Therapeutics | 1 | $81 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: ZEPBOUND, EVENITY, Ozempic, Korlym, Rybelsus, JARDIANCE, AIRSUPRA, SHINGRIX.
Industry payments across TX — which companies pay providers there.
